Hypocalcemia, hypomagnesemia, lymphocytopenia, thrombocytopenia, and abnormalities of the thyroid, parathyroid hormone or vitamin D levels may remain undiscovered in 22q11.2 deletion patients, especially without genetic diagnosis. This evidence concerns the gene PTH and Thrombocytopenia.